Cargando…

Epigenetic Regulation of Glucose Transporters in Non-Small Cell Lung Cancer

Due to their inherently hypoxic environment, cancer cells often resort to glycolysis, or the anaerobic breakdown of glucose to form ATP to provide for their energy needs, known as the Warburg effect. At the same time, overexpression of the insulin receptor in non-small cell lung cancer (NSCLC) is as...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Byrne, Kenneth J., Baird, Anne-Marie, Kilmartin, Lisa, Leonard, Jennifer, Sacevich, Calen, Gray, Steven G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757377/ https://www.ncbi.nlm.nih.gov/pubmed/24212773 http://dx.doi.org/10.3390/cancers3021550

Ejemplares similares

Epigenetics Underpinning the Regulation of the CXC (ELR(+)) Chemokines in Non-Small Cell Lung Cancer
por: Baird, Anne-Marie, et al.
Publicado: (2011)

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer
por: Baird, Anne-Marie, et al.
Publicado: (2013)

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
por: O'Byrne, Kenneth J., et al.
Publicado: (2011)

Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy
por: Lawless, Matthew W, et al.
Publicado: (2009)

Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model
por: Baird, Anne-Marie, et al.
Publicado: (2016)

SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer
por: Burgess, Joshua T., et al.
Publicado: (2020)

MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer
por: MacDonagh, Lauren, et al.
Publicado: (2021)

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
por: Barr, Martin P, et al.
Publicado: (2015)

Computed tomography texture analysis of response to second-line nivolumab in metastatic non-small cell lung cancer
por: Ladwa, Rahul, et al.
Publicado: (2020)

Correction to: Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
por: Barr, Martin P., et al.
Publicado: (2020)

USO1 expression is dysregulated in non-small cell lung cancer
por: Keogh, Anna, et al.
Publicado: (2022)

Rearranged During Transfection Fusions in Non-Small Cell Lung Cancer
por: O’Leary, Connor, et al.
Publicado: (2019)

Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin
por: MacDonagh, Lauren, et al.
Publicado: (2021)

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer
por: Cathcart, Mary-Clare, et al.
Publicado: (2011)

Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo
por: Cathcart, Mary-Clare, et al.
Publicado: (2016)

Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer
por: Ryan, Sarah-Louise, et al.
Publicado: (2021)

Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
por: Barr, Martin P., et al.
Publicado: (2013)

Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells
por: Circu, Magdalena, et al.
Publicado: (2017)

Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
por: Barr, Martin P., et al.
Publicado: (2020)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer
por: Kapeleris, Joanna, et al.
Publicado: (2020)

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer
por: Swinson, D E B, et al.
Publicado: (2004)

Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells
por: Circu, Magdalena, et al.
Publicado: (2018)

Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review
por: Fernandez, Alejandra, et al.
Publicado: (2021)

Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel
por: Zhou, Jian, et al.
Publicado: (2019)

Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?
por: Ahern, Elizabeth, et al.
Publicado: (2021)

Stochastic epithelial-mesenchymal transitions diversify non-cancerous lung cell behaviours
por: Bhatia, Sugandha, et al.
Publicado: (2023)

Heterogeneity of Glucose Transport in Lung Cancer
por: Martinez, Cesar A., et al.
Publicado: (2020)

Bone matters in lung cancer
por: Brodowicz, T., et al.
Publicado: (2012)

Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
por: Pinski, J., et al.
Publicado: (1994)

High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC)
por: Monkman, James, et al.
Publicado: (2020)

Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
por: Suraweera, Amila, et al.
Publicado: (2020)

Glucose transporters in the small intestine in health and disease
por: Koepsell, Hermann
Publicado: (2020)

Pseudouridine guides germline small RNA transport and epigenetic inheritance
por: Herridge, Rowan P, et al.
Publicado: (2023)

Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
por: Suraweera, Amila, et al.
Publicado: (2021)

The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer
por: Kulasinghe, Arutha, et al.
Publicado: (2018)

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
por: O’Leary, Connor, et al.
Publicado: (2020)

Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Recent advances in understanding glucose transport and glucose disposal
por: Olson, Ann Louise, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8p5ksm08l3enet6qgcj2cifvpe